Please login to the form below

Not currently logged in
Email:
Password:

Ultibro Breezhaler

This page shows the latest Ultibro Breezhaler news and features for those working in and with pharma, biotech and healthcare.

Novartis signs 'connected inhaler' deal with Propeller Health

Novartis signs 'connected inhaler' deal with Propeller Health

Novartis and Propeller will connect the Breezhaler devices to Propeller's digital platform via a new custom sensor will passively record and transmit treatment compliance data. ... The inhaler is currently used as part of Novartis' Ultibro Breezhaler,

Latest news

  • Vectura to merge with SkyePharma in £441m deal Vectura to merge with SkyePharma in £441m deal

    Vectura recorded revenues of £26m in the six-month period ended September 2015 - up 35% - as royalties increased on products such as Novartis' Ultibro Breezhaler (indacaterol/glycopyrronium bromide).

  • Novartis sets sights on connected inhaler Novartis sets sights on connected inhaler

    The next-generation Breezhaler falls within the pharma firm's collaboration with Qualcomm, whose Qualcomm Life subsidiary provides wireless solutions for the management of chronic diseases and sharing of medical information. ... Novartis plans a 2019

  • Novartis' combo COPD inhaler cleared in EU Novartis' combo COPD inhaler cleared in EU

    Becomes first dual action bronchodilator approved in EU for COPD. Novartis' Ultibro Breezhaler has become the first dual action bronchodilator to be approved in the EU for chronic obstructive pulmonary disease ... Many COPD patients will now have a

  • Boehringer’s first cancer drug leads EMA recommendations Boehringer’s first cancer drug leads EMA recommendations

    Novartis COPD inhaler recommended in EU. Elsewhere among the CHMP's recommendations, Novartis received backing for the Ultibro Breezhaler as a once-daily maintenance treatment to relive symptoms in adults with ... The product, which is to be marketed as

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics